Product Information
DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.9418 per EA under NDC 00591039860. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 9, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75; 200 mg/1; ug/1
Manufacturer
Actavis Pharma, Inc.NDC
00591039860
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
Generic (ANDA)
FDA Application
ANDA201089FDA Approved
7/9/2012
TE Code
AB
On Market Since
11/1/2012
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 59.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9418 per EA |
|---|---|
| All-time high | $2.4670 (Mar 12, 2014) |
| All-time low | $0.7254 (Nov 20, 2024) |
| 52-week high | $1.0906 |
| 52-week low | $0.9418 |
| Median price | $1.7250 |
| Average price | $1.6909 |
| Largest weekly change | -39.0% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.9418 per EA (NDC 00591039860), effective Aug 19, 2026.
How has the price of DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET has declined 59.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
Since Nov 28, 2013, the NADAC for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET has ranged from a low of $0.7254 (Nov 20, 2024) to a high of $2.4670 (Mar 12, 2014), with a median of $1.7250 per EA.
Are there cheaper alternatives to DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET (NDC 00591039860) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.